Search PubMed⌕ Search

Biomedical subjects

B Patsner

Publications and source records attributed to B Patsner.

94 records · Page 6Linked to original sources
PubMed1985

Clinically localized ovarian cancer. Progress in management.

A decade ago the five-year survival rate in patients with stage I ovarian carcinoma was only 60% to 70%. Significant advances in staging and treatment, however, promise an improvement. Initially, improvement will be seen because some patients with clinically localized ovarian cancer will be discovered to have subclinical or occult metastasis at initial surgical staging and thus will be upstaged and treated appropriately for more advanced disease. More encouraging are results of recent studies on adjuvant therapy, which indicate that in some patients the need for postoperative adjuvant therapy may be obviated. A major advance in diagnosis would be development of a serum test specific for ovarian cancer--a discovery that may be forthcoming.

Adult↗
PubMed1984

Pseudomyxoma peritonei: possible prevention of mucinous ascites by peritoneal lavage.

Combined use of intraperitoneal lavage with dextrose 5% and water and an aggressive surgical approach has thus far successfully prevented reaccumulation of pseudomyxoma peritonei originating from bilateral ovarian mucinous cystadenoma associated with multiple peritoneal implants. Three and a half years after treatment the patient remains without clinical or ultrasonographic evidence of recurrence.

Ascites↗
PubMed1976

Oral contraceptive patient information. A questionnaire study of attitudes, knowledge, and preferred information sources.

A questionnaire was designed to assess attitudes, knowledge, and views and sources of drug information on oral contraceptives, with particular attention to the role of the patient-oriented package insert. An analysis of 828 completed questionnaires shows that many women are apprehensive about the safety of oral contraceptives. The impact of the patient-oriented oral contraceptive insert on the women surveyed appears to be positive. The present labeling is read and found useful by most oral-contraceptive users. Patients were variably informed about the correct use and side effects discussed in current labeling, suggesting a need for improved transmission of important drug information. Patients preferred information from health professionals and printed sources over media sources. Balanced label information about risks of oral contraceptives should be made available to improve the likelihood of sound risk-benefit judgments.

Adolescent↗